FDA Inspection 1081144 — Diasorin Inc.
The FDA completed an inspection of Diasorin Inc. on February 1, 2019 in Stillwater, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 1, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Stillwater, MN (United States)
Additional Details
Sponsor, Contract Research Organization